Kbc Group Nv Lantheus Holdings, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 1,898 shares of LNTH stock, worth $169,472. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,898

Previous 1,649 15.1%

Holding current value

$169,472

Previous $132,000 57.58%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$77.7 - $123.62 $19,347 - $30,781	249 Added 15.1%	1,898 $208,000
Q1 2024 May 08, 2024	BUY	$51.07 - $68.26 $16,035 - $21,433	314 Added 23.52%	1,649 $103,000
Q4 2023 Feb 13, 2024	BUY	$55.6 - $77.89 $74,226 - $103,983	1,335 New	1,335 $83,000
Q3 2023 Feb 15, 2024	SELL	$60.27 - $90.75 $280,134 - $421,806	-4,648 Reduced 77.69%	1,335 $93,000
Q3 2022 Feb 15, 2024	BUY	$61.42 - $86.29 $285,480 - $401,075	4,648 Added 348.16%	5,983 $421,000
Q3 2022 Nov 08, 2022	BUY	$61.42 - $86.29 $48,767 - $68,514	794 Added 15.3%	5,983 $421,000
Q2 2022 Feb 14, 2024	BUY	$55.54 - $72.65 $214,051 - $279,993	3,854 Added 288.69%	5,189 $343,000
Q2 2022 Jul 26, 2022	BUY	$55.54 - $72.65 $288,197 - $376,980	5,189 New	5,189 $343,000
Q1 2021 Apr 26, 2021	SELL	$13.77 - $21.66 $54,336 - $85,470	-3,946 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$11.98 - $16.34 $41,211 - $56,209	-3,440 Reduced 46.57%	3,946 $50,000
Q2 2020 Aug 10, 2020	BUY	$10.34 - $15.51 $58,090 - $87,135	5,618 Added 317.76%	7,386 $106,000
Q1 2020 May 04, 2020	SELL	$9.11 - $20.05 $229,034 - $504,077	-25,141 Reduced 93.43%	1,768 $23,000
Q3 2019 Nov 07, 2019	BUY	$21.01 - $28.94 $212,264 - $292,380	10,103 Added 60.12%	26,909 $674,000
Q2 2019 Jul 30, 2019	BUY	$23.33 - $28.3 $392,083 - $475,609	16,806 New	16,806 $0

Others Institutions Holding LNTH

# of Institutions

540

Shares Held

68M

Call Options Held

679K

Put Options Held

423K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account